MAM
BIOL

Meeder Asset Management’s Biolase, Inc. BIOL Stock Holding History

Meeder Asset Management’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Hold
0
– -$2K – 871
2015
Q3 		– Hold
0
– – – 675
2015
Q2 		– Hold
0
– – – 459
2015
Q1 		– Hold
0
– – – 498
2014
Q4 		– Hold
0
– – – 437
2014
Q3 		– Hold
0
– – – 360
2014
Q2 		– Hold
0
– – – 328
2014
Q1 		– Hold
0
– – – 323
2013
Q4 		– Hold
0
– – – 341
2013
Q3 		– Hold
0
– – – 348
2013
Q2 		– Hold
0
– – – 339

Other funds holding BIOL

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
PCMI
Princeton Capital Management Inc Princeton, New Jersey $198M AUM 28.98% 1-Year Est. Return
TA
Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return